Mpox Global Response Plan: Key Strategies for Outbreak Control

"This plan supports countries facing an acute mpox crisis or at high risk. It focuses on enhancing surveillance, lab capacity, community protection, clinical care, and vaccination efforts.

1. Case Projections and Resource Needs:

• 1,000 weekly cases, potentially doubling in the first two months.
• Resources: 500 PCR tests, 5,000 RDTs, 20,000 vaccines weekly, treatment for 900 home cases, and 100 hospitalizations.
• Phase 1 of vaccination targets healthcare workers, requiring 2 million doses.
• Total cost: $135.8 million for coordination, technical support, and supplies.

1. Monitoring and Evaluation:

• Indicators: surveillance coverage, case detection, vaccination rates, treatment outcomes, and community engagement.
• Data disaggregated by age, gender, and location to guide interventions.
• Real-time dashboards and regular progress reviews to adapt the response.

1. Phased Vaccination Strategy:

• Phase 1: Vaccinate contacts of cases and healthcare workers in outbreak areas.
• Phase 2: Protect high-risk individuals.
• Phase 3: Increase population immunity in at-risk regions.

1. Strategic Objectives:

• Strengthen surveillance and rapid response.
• Tailor interventions to community needs.
• Provide scalable, safe care with proper guidelines.
• Advance research and ensure equitable access to treatments.
• Collaborate across health sectors to prevent human-animal transmission.

Source:https://www.who.int/publications/m/item/mpox-global-strategic-preparedness-and-response-plan##~https://cdn.who.int/media/docs/default-source/documents/health-topics/monkeypox/draft_sprp_mpox_2024.pdf?sfvrsn=6d9df725_3&download=true

Region: All Markets